GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enimmune Corp (ROCO:6564) » Definitions » Buildings And Improvements

Enimmune (ROCO:6564) Buildings And Improvements : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Enimmune Buildings And Improvements?


Enimmune Buildings And Improvements Historical Data

The historical data trend for Enimmune's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enimmune Buildings And Improvements Chart

Enimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buildings And Improvements
Get a 7-Day Free Trial - - - - -

Enimmune Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Enimmune Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.


Enimmune Business Description

Traded in Other Exchanges
N/A
Address
Dunhua South Road, 18th Floor-2, No. 76, Section 2, Da’an District, Taipei, TWN, 10683
Enimmune Corp is primarily engaged in the research and development and trading of vaccines, testing reagents and biotechnology services, etc., as well as trading of related western medicines.

Enimmune Headlines

No Headlines